ScripsAmerica's Diabetes Patient Supply Program En
Post# of 7769
Posted On: 02/18/2015 8:03:32 AM
ScripsAmerica's Diabetes Patient Supply Program Enrolls 500th Patient
ScripsAmerica's Diabetes Patient Supply Program Enrolls 500th Patient
TYSONS CORNER, Va., Feb. 18, 2015 (GLOBE NEWSWIRE) -- ScripsAmerica, Inc. (OTCBB:SCRC) today announced that the Company's diabetes patient supply program, run through its wholly-owned subsidiary Main Avenue Pharmacy, has enrolled its 500(th) patient.
"Scrips is pleased to announce the strong initial growth of our diabetes supply program. In just its second month, Main Avenue Pharmacy has achieved an early milestone of enrolling five hundred patients," commented Bob Schneiderman, ScripsAmerica's CEO. "We expect to continue growing this program as we direct our efforts toward serving America's underserved Hispanic population, which is at higher risk for type 2 diabetes than non-Hispanic Caucasians, according to recent studies."
Main Avenue Pharmacy, wholly owned subsidiary of ScripsAmerica, provides diabetes patients in certain states with medical supplies that are only available through a physician's prescription and typically covered by medical insurance and Medicare, through the recently announced program. Medical supplies that the Company provides include, but are not limited to meters, test strips, swabs, pens, lancing devices and lancets.
For more information on the prevalence of diabetes within the US Hispanic/Latino population, read the following articles published by the "American Diabetes Association" and the "National Institutes of Health."
About ScripsAmerica, Inc.
ScripsAmerica, Inc. is a supplier of prescription, OTC and nutraceutical drugs, delivering pharmaceutical products to a wide range of end users across the health care industry. End users include retail pharmacies, hospitals, long-term care facilities and government and home care agencies. For more information, visit www.ScripsAmerica.com.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
CONTACT: Seal Point Consulting, LLC
888-959-7095
ir@sealpointconsulting.com
(MORE TO FOLLOW) Dow Jones Newswires
February 18, 2015 08:00 ET (13:00 GMT)
ScripsAmerica's Diabetes Patient Supply Program Enrolls 500th Patient
TYSONS CORNER, Va., Feb. 18, 2015 (GLOBE NEWSWIRE) -- ScripsAmerica, Inc. (OTCBB:SCRC) today announced that the Company's diabetes patient supply program, run through its wholly-owned subsidiary Main Avenue Pharmacy, has enrolled its 500(th) patient.
"Scrips is pleased to announce the strong initial growth of our diabetes supply program. In just its second month, Main Avenue Pharmacy has achieved an early milestone of enrolling five hundred patients," commented Bob Schneiderman, ScripsAmerica's CEO. "We expect to continue growing this program as we direct our efforts toward serving America's underserved Hispanic population, which is at higher risk for type 2 diabetes than non-Hispanic Caucasians, according to recent studies."
Main Avenue Pharmacy, wholly owned subsidiary of ScripsAmerica, provides diabetes patients in certain states with medical supplies that are only available through a physician's prescription and typically covered by medical insurance and Medicare, through the recently announced program. Medical supplies that the Company provides include, but are not limited to meters, test strips, swabs, pens, lancing devices and lancets.
For more information on the prevalence of diabetes within the US Hispanic/Latino population, read the following articles published by the "American Diabetes Association" and the "National Institutes of Health."
About ScripsAmerica, Inc.
ScripsAmerica, Inc. is a supplier of prescription, OTC and nutraceutical drugs, delivering pharmaceutical products to a wide range of end users across the health care industry. End users include retail pharmacies, hospitals, long-term care facilities and government and home care agencies. For more information, visit www.ScripsAmerica.com.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
CONTACT: Seal Point Consulting, LLC
888-959-7095
ir@sealpointconsulting.com
(MORE TO FOLLOW) Dow Jones Newswires
February 18, 2015 08:00 ET (13:00 GMT)
(0)
(0)